Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Plunkett

Showing results (241-250 of 244) with videos related to

Pageof 25
Sort By:
You have reached the last page of results.This site can display upto 244 results.
Leukemia & Lymphoma|December 29, 1999
Sequential cis-platinum and fludarabine with or without arabinosyl cytosine in patients failing prior fludarabine therapy for chronic lymphocytic leukemia: a phase II studyF J Giles, S M O'Brien, V Santini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 1998
Compound GW506U78 in refractory hematologic malignancies: relationship between cellular pharmacokinetics and clinical responseV Gandhi, W Plunkett, C O Rodriguez, et al.
Cancer Research|October 1, 1979
Penetration of 3-deazauridine into human brain, intracerebral tumor, and cerebrospinal fluidD J Stewart, J A Benvenuto, M Leavens, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2001
Evaluation of the combination of nelarabine and fludarabine in leukemias: clinical response, pharmacokinetics, and pharmacodynamics in leukemia cellsV Gandhi, W Plunkett, S Weller, et al.
Pageof 25

Showing results (241-250 of 244) with videos related to

Sort By:
Pageof 25
You have reached the last page of results.This site can display upto 244 results.
Leukemia & Lymphoma|December 29, 1999
Sequential cis-platinum and fludarabine with or without arabinosyl cytosine in patients failing prior fludarabine therapy for chronic lymphocytic leukemia: a phase II studyF J Giles, S M O'Brien, V Santini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 1998
Compound GW506U78 in refractory hematologic malignancies: relationship between cellular pharmacokinetics and clinical responseV Gandhi, W Plunkett, C O Rodriguez, et al.
Cancer Research|October 1, 1979
Penetration of 3-deazauridine into human brain, intracerebral tumor, and cerebrospinal fluidD J Stewart, J A Benvenuto, M Leavens, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2001
Evaluation of the combination of nelarabine and fludarabine in leukemias: clinical response, pharmacokinetics, and pharmacodynamics in leukemia cellsV Gandhi, W Plunkett, S Weller, et al.
Pageof 25